NRT Smoking Cessation Aids in the Czech Republic
Euromonitor International's NRT Smoking Cessation Aids in the Czech Republic market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 27 | Publication date: Nov 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
NRT gum; NRT inhalators; NRT lozenges; NRT patches; Other NRT
Table of contents
NRT SMOKING CESSATION AIDS IN THE CZECH REPUBLIC : MARKET INSIGHT
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
SWITCHES
PROSPECTS
SECTOR INDICATORS
Table 1 Number of Smokers by Gender 2003-2008
SECTOR DATA
Table 2 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
Table 3 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
Table 4 NRT Gum Flavours: % Value Breakdown 2006-2008
Table 5 Smoking Cessation Aids Company Shares by Value 2004-2008
Table 6 Smoking Cessation Aids Brand Shares by Value 2005-2008
Table 7 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
Table 8 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013
LOCAL COMPANY PROFILES - CZECH REPUBLIC
HERBACOS BOFARMA SRO - OTC HEALTHCARE - CZECH REPUBLIC
STRATEGIC DIRECTION
KEY FACTS
Summary 1 Herbacos Bofarma sro: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 2 Herbacos Bofarma sro: Competitive Position 2008
VITAR SRO - OTC HEALTHCARE - CZECH REPUBLIC
STRATEGIC DIRECTION
KEY FACTS
Summary 3 Vitar sro: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 4 Vitar sro: Competitive Position 2008
WALMARK AS - OTC HEALTHCARE - CZECH REPUBLIC
STRATEGIC DIRECTION
KEY FACTS
Summary 5 Walmark as: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
ZENTIVA AS - OTC HEALTHCARE - CZECH REPUBLIC
STRATEGIC DIRECTION
KEY FACTS
Summary 6 Zentiva as: Key Facts
Summary 7 Zentiva as: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
OTC HEALTHCARE IN THE CZECH REPUBLIC
EXECUTIVE SUMMARY
Impact of global financial crisis on the economy
Mandatory fees yield some positive changes
OTC healthcare market continues dynamic growth
Domestic manufacturers dominate market
Changing lifestyles drive demand for OTC healthcare
Positive outlook for forecast period
KEY TRENDS AND DEVELOPMENTS
Mandatory fees boost sales of OTC healthcare products
Fast-paced lifestyle increases demand for OTC healthcare products
Strong growth of child-specific OTC healthcare products
Pharmacies become an interesting specialised store
MARKET INDICATORS
Table 9 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 10 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 11 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 12 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 13 OTC Healthcare Company Shares by Value 2004-2008
Table 14 OTC Healthcare Brand Shares by Value 2005-2008
Table 15 Penetration of Private Label by Sector 2003-2008
Table 16 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 17 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 18 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 19 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Generics
DEFINITIONS
Summary 8 Research Sources